Skip to content

Tinaquant Lipoprotein a Gen.2 5852633190Recalls & reported problems

Roche Diagnostics GmbH · Class 2

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
2
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 04015630930586), received between Feb 21, 2025 and Mar 24, 2026 — classified as 2 malfunctions.

The most frequently reported specific device problem is “Low Test Results” (2 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 1 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 1 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Low Test Results2
  • Non Reproducible Results2
  • Chemical Problem1

Patient problems

  • No Clinical Signs, Symptoms or Conditions2

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • MalfunctionMar 24, 2026Low Test Results; Non Reproducible Results

    THE INITIAL REPORTER COMPLAINED OF A DISCREPANT LOW RESULT FOR 1 PATIENT SAMPLE TESTED FOR TINA-QUANT LIPOPROTEIN (A) GEN.2 (LPA2) ON A COBAS 8000 COBAS C 701 MODULE. THE INITIAL RESULT WAS 236 NMOL/L. THIS RESULT WAS QUESTIONED BY THE PHYSICIAN, AND THE SAMPLE WAS REPEATED. THE REPEAT RESULT WAS 248.0 NMOL/L, ACCOMPANIED BY AN INVALIDATING DATA FLAG. THE REPEAT RESULT WAS 1213.5 NMOL/L. THE SAMPLE WAS REPEATED WITH A 1:3 DILUTION, AND THE RESULT WAS 1206.0 NMOL/L, ACCOMPANIED BY AN INVALIDATING DATA FLAG. THE SAMPLE WAS REPEATED WITH A 1:5 DILUTION, AND THE RESULT WAS 1431.5 NMOL/L, ACCOMPANIED BY AN INVALIDATING FLAG. THE SAMPLE WAS REPEATED WITH A 1:20 DILUTION, AND THE RESULT WAS 951.1 NMOL/L.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 24681101 ↗
  • MalfunctionFeb 21, 2025Low Test Results; Chemical Problem; Non Reproducible Results; Low Test Results; Chemical Problem; Non Reproducible Results

    THERE WAS AN ALLEGATION OF A QUESTIONABLE TINA-QUANT LIPOPROTEIN (A) GEN.2 RESULT FROM THE COBAS 8000 ISE 1800 MODULE. THE INITIAL RESULT WAS 230 NMOL/L, AND THE REPEAT RESULT ON A SIEMENS ANALYZER WAS 579 NMOL/L. THERE WAS ANOTHER TEST COMPLETED ON THE C 701 FROM THE SAME SAMPLE WITH DILUTION THAT GAVE A RESULT OF > TEST. THE QUESTIONABLE RESULT WAS REPEATED BECAUSE IT DID NOT MATCH THE PREVIOUS RESULTS. THE RESULTS OF 579 NMOL/L MATCHED WITH PREVIOUS RESULTS.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 21433840 ↗

Other LIPOPROTEIN, LOW-DENSITY, ANTIGEN, ANTISERUM, CONTROL devices

All LIPOPROTEIN, LOW-DENSITY, ANTIGEN, ANTISERUM, CONTROL devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page